Autism spectrum disorder (ASD) is a multifactorial, pervasive neurodevelopmental disorder defined by the core symptoms of significant impairment in social interaction and communication as well as restricted, repetitive patterns of behavior. In addition to these core behaviors, persons with ASD frequently have associated noncore behavioral disturbance (ie, self-injury, aggression), as well as several medical comorbidities. Currently, no effective treatment exists for the core symptoms of ASD. This review reports the available preclinical and clinical data regarding the use of cannabis and cannabidiol in the treatment of core symptoms, noncore symptoms and comorbidities associated with ASD. Additionally, we describe our clinical experience working with children and young adults with ASD who have used cannabis or cannabidiol. At present, preclinical and clinical data suggest a potential for therapeutic benefit among some persons with ASD and that it is overall well tolerated. Further research is required to better identify patients who may benefit from treatment without adverse effects.
Copyright © 2020 Elsevier Inc. All rights reserved.
2020 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32491480 Free Books & Documents. Review.
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30171992 Review.
Methylphenidate for children and adolescents with autism spectrum disorder.
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article. Review.
Autism Spectrum Disorder: Classification, diagnosis and therapy.
Pharmacol Ther. 2018 Oct;190:91-104. doi: 10.1016/j.pharmthera.2018.05.007. Epub 2018 May 12. Pharmacol Ther. 2018. PMID: 29763648 Review.
Shorter sleep duration is associated with social impairment and comorbidities in ASD.
Autism Res. 2017 Jul;10(7):1221-1238. doi: 10.1002/aur.1765. Epub 2017 Mar 16. Autism Res. 2017. PMID: 28301091